HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Namura Selected Research

S Namura Research Topics

Disease

4Brain Ischemia (Cerebral Ischemia)
12/2001 - 06/2001
4Stroke (Strokes)
12/2001 - 05/2000
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2001 - 05/2000
4Ischemia
09/2001 - 09/2000
3Brain Injuries (Brain Injury)
12/2001 - 05/2000
3Infarction (Infarctions)
12/2001 - 06/2001
1Neoplasms (Cancer)
01/2003
1Reperfusion Injury
09/2001
1Brain Infarction
06/2001
1Hypoxia (Hypoxemia)
07/2000

Drug/Important Bio-Agent (IBA)

2U 0126 (UO 126)IBA
09/2001 - 07/2000
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2001 - 07/2000
2Halothane (Fluothane)FDA Link
08/2001 - 06/2001
1Proteins (Proteins, Gene)FDA Link
01/2003
1Chemokine ReceptorsIBA
12/2001
1vMIP-IIIBA
12/2001
1Chemokine CCL3IBA
12/2001
1Peptides (Polypeptides)IBA
12/2001
1Messenger RNA (mRNA)IBA
12/2001
1ChemokinesIBA
12/2001
1CC ChemokinesIBA
12/2001
1Mitogen-Activated Protein KinasesIBA
09/2001
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
09/2001
1Cytochromes c (Cytochrome c)IBA
08/2001
1ebselenIBA
08/2001
1Matrix Metalloproteinase InhibitorsIBA
06/2001
1KB R7785IBA
06/2001
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2000
1Glutamic Acid (Glutamate)FDA Link
07/2000
1trichostatin A (A 300)IBA
05/2000
1Caspase 3 (Caspase-3)IBA
05/2000
1DecitabineFDA Link
05/2000
1DNA (Deoxyribonucleic Acid)IBA
05/2000
1CytokinesIBA
05/2000
1MethyltransferasesIBA
05/2000

Therapy/Procedure

2Anesthesia
08/2001 - 06/2001
1Intravenous Administration
09/2001
1Therapeutics
08/2001